AKAM
50
2
F
38
4
L
54
5
LUV
45
3
CHD
34
7
HAS
29
3
DD
44
2
EQIX
59
2
INTC
35
4
STT
48
4
GOOG
77
14
UAL
73
3
PEP
33
4
ROK
46
3
DOW
47
4
USB
50
3
GIS
47
13
NI
63
5
EXPD
29
2
NEE
39
9
AKAM
50
2
F
38
4
L
54
5
LUV
45
3
CHD
34
7
HAS
29
3
DD
44
2
EQIX
59
2
INTC
35
4
STT
48
4
GOOG
77
14
UAL
73
3
PEP
33
4
ROK
46
3
DOW
47
4
USB
50
3
GIS
47
13
NI
63
5
EXPD
29
2
NEE
39
9
Financhill
Back

Akari Therapeutics PLC Vs. Cellectis SA Industry Stock Comparison

Sell
14

AKTX
Akari Therapeutics PLC

Last Price:
$0.95
Seasonality Move:
-8.16%
Sell
34

CLLS
Cellectis SA

Last Price:
$1.58
Seasonality Move:
-10.57%
Sell
14
Akari Therapeutics PLC (AKTX) is a Sell

Is Akari Therapeutics PLC a Buy, Sell or Hold?

  • The current Akari Therapeutics PLC [AKTX] share price is $0.97. The Score for AKTX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • AKTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
34
Cellectis SA (CLLS) is a Sell

Is Cellectis SA a Buy, Sell or Hold?

  • The current Cellectis SA [CLLS] share price is $1.61. The Score for CLLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CLLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKTX Stock Price Chart

What is Akari Therapeutics PLC's stock price today?

  • The Akari Therapeutics PLC share price today is $0.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTX is experiencing slight selling pressure.

CLLS Stock Price Chart

What is Cellectis SA's stock price today?

  • The Cellectis SA share price today is $1.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 31.31 Sell
Chaikin Money Flow: -13697 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.91 - 1.57) Sell
Bollinger Bands (100): (1.66 - 3.5) Sell

CLLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 31.65 Sell
Chaikin Money Flow: 71561 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.74 - 2.04) Sell
Bollinger Bands (100): (1.83 - 2.23) Sell

AKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.98 Sell
20-day SMA: 1.12 Sell
50-day SMA: 1.81 Sell
200-day SMA: 2.42 Sell
8-day EMA: 1.01 Sell
20-day EMA: 1.2 Sell
50-day EMA: 1.73 Sell
200-day EMA: 2.59 Sell

CLLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.72 Sell
20-day SMA: 1.89 Sell
50-day SMA: 1.88 Sell
200-day SMA: 2.26 Sell
8-day EMA: 1.71 Sell
20-day EMA: 1.82 Sell
50-day EMA: 1.9 Sell
200-day EMA: 2.17 Sell

Akari Therapeutics PLC Earnings Growth & AKTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.

Cellectis SA Earnings Growth & CLLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and a decrease next year of $0.06 per share.

Akari Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cellectis SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):